MX378251B - Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. - Google Patents
Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.Info
- Publication number
- MX378251B MX378251B MX2015009155A MX2015009155A MX378251B MX 378251 B MX378251 B MX 378251B MX 2015009155 A MX2015009155 A MX 2015009155A MX 2015009155 A MX2015009155 A MX 2015009155A MX 378251 B MX378251 B MX 378251B
- Authority
- MX
- Mexico
- Prior art keywords
- alpha
- acetylcholine receptor
- nicotinic acetylcholine
- receptor agonists
- facilitation
- Prior art date
Links
- 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 title abstract 2
- 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 title abstract 2
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- 229940122578 Acetylcholine receptor agonist Drugs 0.000 abstract 1
- 238000002695 general anesthesia Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere al uso de cierto agonista del receptor nicotínico de acetilcolina alfa 7 para facilitar la recuperación de la anestesia general.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361752772P | 2013-01-15 | 2013-01-15 | |
| PCT/IB2014/058225 WO2014111838A1 (en) | 2013-01-15 | 2014-01-13 | Use of alpha 7 nicotinic acetylcholine receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015009155A MX2015009155A (es) | 2016-03-04 |
| MX378251B true MX378251B (es) | 2025-03-10 |
Family
ID=50070639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015009155A MX378251B (es) | 2013-01-15 | 2014-01-13 | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2945633B1 (es) |
| JP (1) | JP6338223B2 (es) |
| KR (1) | KR101879920B1 (es) |
| CN (1) | CN105263495B (es) |
| BR (1) | BR112015016995B8 (es) |
| CA (1) | CA2898080C (es) |
| ES (1) | ES2883232T3 (es) |
| MX (1) | MX378251B (es) |
| TW (1) | TWI633886B (es) |
| WO (1) | WO2014111838A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020001425A (es) | 2017-08-04 | 2020-08-06 | Skyhawk Therapeutics Inc | Metodos y composiciones para modular el empalme. |
| EP3713574A4 (en) * | 2017-11-22 | 2021-08-04 | The Governors of the University of Alberta | PROCESS FOR CONTROLLING RESPIRATORY DEPRESSION BY ACTIVATION OF NICOTINIC NEURAL ACETYLCHOLINE RECEPTORS HETEROMERIC |
| WO2020163248A1 (en) | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| WO2020163541A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| KR102913697B1 (ko) | 2019-02-05 | 2026-01-15 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| KR102925385B1 (ko) | 2019-02-06 | 2026-02-11 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| CN115192558B (zh) * | 2021-04-02 | 2023-12-29 | 四川大学华西医院 | 一种环状酮类化合物的用途 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| GB0010955D0 (en) | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| GB0220581D0 (en) * | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| CA2499128C (en) | 2002-09-25 | 2012-07-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| WO2006065233A1 (en) | 2004-12-10 | 2006-06-22 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| US20050245531A1 (en) | 2003-12-22 | 2005-11-03 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| GB0412019D0 (en) | 2004-05-28 | 2004-06-30 | Novartis Ag | Organic compounds |
| PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
| GB0415746D0 (en) * | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
| GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| TW200813067A (en) | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
| NZ573735A (en) | 2006-05-19 | 2011-10-28 | Abbott Lab | Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives |
| US8314119B2 (en) | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| CN100448468C (zh) * | 2006-11-14 | 2009-01-07 | 赵玉民 | 一种口服用于治疗胃病的药粉 |
| SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| WO2009066107A1 (en) | 2007-11-21 | 2009-05-28 | Astrazeneca Ab | Use of a nicotinic receptor agonist |
| WO2010043515A1 (en) | 2008-10-13 | 2010-04-22 | F. Hoffmann-La Roche Ag | Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides |
| CN102209540A (zh) * | 2008-11-11 | 2011-10-05 | 塔加西普特公司 | 使用α7-选择性配体的治疗方法 |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| TWI558398B (zh) * | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α7活化劑之用途 |
| HRP20150560T2 (hr) * | 2010-11-10 | 2015-11-20 | H. Lundbeck A/S | Radiooznaäśeni ligandi na bazi fenilimidazola |
| US20140171448A1 (en) * | 2011-01-27 | 2014-06-19 | Novartis Ag | Use of nicotinic acetylcholine receptor alpha 7 activators |
| CN103619354A (zh) * | 2011-06-30 | 2014-03-05 | 东丽株式会社 | 止痒剂 |
-
2014
- 2014-01-13 EP EP14703426.8A patent/EP2945633B1/en active Active
- 2014-01-13 KR KR1020157021931A patent/KR101879920B1/ko active Active
- 2014-01-13 CA CA2898080A patent/CA2898080C/en active Active
- 2014-01-13 ES ES14703426T patent/ES2883232T3/es active Active
- 2014-01-13 MX MX2015009155A patent/MX378251B/es unknown
- 2014-01-13 JP JP2015552186A patent/JP6338223B2/ja active Active
- 2014-01-13 BR BR112015016995A patent/BR112015016995B8/pt active IP Right Grant
- 2014-01-13 CN CN201480014741.3A patent/CN105263495B/zh active Active
- 2014-01-13 WO PCT/IB2014/058225 patent/WO2014111838A1/en not_active Ceased
- 2014-01-14 TW TW103101309A patent/TWI633886B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014111838A1 (en) | 2014-07-24 |
| BR112015016995B1 (pt) | 2022-02-01 |
| EP2945633A1 (en) | 2015-11-25 |
| TW201440766A (zh) | 2014-11-01 |
| BR112015016995B8 (pt) | 2022-07-26 |
| CA2898080C (en) | 2018-01-09 |
| JP6338223B2 (ja) | 2018-06-06 |
| CN105263495B (zh) | 2019-05-14 |
| JP2016509595A (ja) | 2016-03-31 |
| ES2883232T3 (es) | 2021-12-07 |
| KR20150105469A (ko) | 2015-09-16 |
| BR112015016995A8 (pt) | 2018-01-23 |
| CN105263495A (zh) | 2016-01-20 |
| EP2945633B1 (en) | 2021-06-30 |
| MX2015009155A (es) | 2016-03-04 |
| TWI633886B (zh) | 2018-09-01 |
| BR112015016995A2 (pt) | 2017-07-11 |
| CA2898080A1 (en) | 2014-07-24 |
| KR101879920B1 (ko) | 2018-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019001224A1 (es) | Composiciones de células t con car anti--bcma. | |
| DK3762380T3 (da) | Phenylpyrrolidinon-formylpeptid-2-receptoragonister | |
| CL2018000920A1 (es) | Conjugados de anticuerpos que comprenden agonistas de receptor similares | |
| CL2017000590A1 (es) | Anticuerpos anti-cll-1 e inmunoconjugados | |
| IL258412A (en) | Melanocortin-4 receptor (mc4r) agonists for use in treating melanocortin-4 receptor pathway-associated disorders | |
| MX2020014121A (es) | Agonistas parciales del receptor de insulina. | |
| MX2015017331A (es) | Anticuerpos anti fc similar a receptor 5 (fcrh5). | |
| CR20150482A (es) | Anticuerpos e inmunoconjugados anti-b7-h4 | |
| MX2016014247A (es) | Conjugados de anticuerpo-farmaco anti-proteina tirosina quinasa 7 (anti-ptk7). | |
| MX2017001079A (es) | Receptores de antígeno quiméricos de antígeno de maduración de células b (bcma). | |
| ECSP13013022A (es) | Agonistas de fgfr1 y sus métodos de uso | |
| CR20160362A (es) | Anticuerpos anti-jagged1 y metodos de uso | |
| ZA202507394B (en) | Semaglutide in cardiovascular conditions | |
| DK3150578T3 (da) | Ny pyrrolidinforbindelse og anvendelse som melanocortin-receptoragonist | |
| MX2015009155A (es) | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. | |
| PL3105186T3 (pl) | Urządzenie do rozpraszania u źródła emisji wyziewów gazowych powodujących mdłości | |
| EP3542777A4 (en) | MEDICINAL COMPOSITION FOR ROOT CANAL | |
| TR201909125T4 (tr) | Yüzey temi̇zlemek i̇çi̇n bi̇r aparat | |
| EP3440051A4 (en) | AGROISTS OF NEUROPEPTIDE RECEPTOR (NPSR) | |
| MX379289B (es) | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. | |
| EP3318577A4 (en) | ANTIPLEXIN A1 AGONISTANTIKÖRPER | |
| EP3463413A4 (en) | INSULIN RECEPTOR PART AGONISTS | |
| EP3551011A4 (en) | CART OF MEDICAL INSTRUMENTS | |
| FR3031502B1 (fr) | Ensemble de pointage d'un instrument | |
| GB201619637D0 (en) | C3a receptor agonists |